Background. Patients with IIMs can develop ILD during the course of the disease, however it
is still unclear which patients are at risk for lung involvement. Aim: To identify the …

Background Interstitial lung disease (ILD) is a common pathologic consequence of the
idiopathic inflammatory myopathies, and it may be the initial presentation of autoimmune …

Progressive pulmonary fibrosis is generally diagnosed when interstitial lung disease
progression occurs in the absence of any other cause, and a subset of patients with myositis …

Background Interstitial lung disease (ILD) is a common extramuscular manifestation of the
idiopathic inflammatory myopathies (IIMs), dermatomyositis (DM) and polymyositis (PM) …

Myositis-associated interstitial lung disease (M-ILD) is a heterogeneous group of diseases. It
can be divided into different subtypes listed below according to different myositis …

Introduction Idiopathic inflammatory myopathies (IIMs) encompass a diverse group of
diseases characterized by considerable variability in clinical manifestations, antibody …

Objectives Interstitial lung disease (ILD), one of the most common extramuscular
manifestations of idiopathic inflammatory myopathies (IIMs), carries a poor prognosis …

Rationale: Interstitial lung disease (ILD) is a leading cause of death in patients with systemic
sclerosis (SSc). Many patients with SSc-ILD have co-occurrence of myositis antibodies, the …

Background: Interstitial lung diseases (ILDs) may be idiopathic or related to a known cause,
such as rheumatic autoimmune diseases (ADs). Approximately one third of patients with ILD …

Subtyping myositis is helpful in the management of patients with idiopathic inflammatory
myopathy (IIM). Myositis-specific and myositis-associated autoantibodies are powerful …